Boehringer Offers 92% Discount On Adalimumab Via GoodRx
Chris Marsh, Boehringer’s SVP Of Value And Access, Discusses Deal For Humira Biosimilar
Executive Summary
Boehringer Ingelheim is partnering with GoodRx in the US to offer a version of its Humira biosimilar at a 92% discount to the brand’s list price. Generics Bulletin spoke with Chris Marsh, Boehringer’s senior vice president of value and access, about the initiative.